Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rizatriptan 10 mg RPD for acute migraine with prior inadequate treatment response
2006-000799-33Phase 4Active
- Sponsor
- Universitätsmedizin Essen
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of rizatriptan in migraine, sponsored by Universitätsmedizin Essen. Primary endpoints: Headache response at 2 hours, Headache-free at 2 hours and 2 more. Started Jul 2006; status: active.
02
Drugs
rizatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on 2006-000799-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000799-33.